Crossref
Conceptualizing the use of the clinical index of liver fibrosis, FIB-4 index, in in vivo preclinical toxicological studies
Archives of Clinical Toxicology · 2023
DOI: 10.46439/toxicology.5.022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Clinical Toxicology, 2023. Verfasst von Kwesi Boadu Mensah.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mensah, K. B. (2023). Conceptualizing the use of the clinical index of liver fibrosis, FIB-4 index, in in vivo preclinical toxicological studies. Archives of Clinical Toxicology. https://doi.org/10.46439/toxicology.5.022
Vancouver
Mensah KB. Conceptualizing the use of the clinical index of liver fibrosis, FIB-4 index, in in vivo preclinical toxicological studies. Archives of Clinical Toxicology. 2023. doi:10.46439/toxicology.5.022
BibTeX
@article{Mensah2023,
author = {Mensah, Kwesi Boadu},
title = {Conceptualizing the use of the clinical index of liver fibrosis, FIB-4 index, in in vivo preclinical toxicological studies},
journal = {Archives of Clinical Toxicology},
year = {2023},
doi = {10.46439/toxicology.5.022}
}
EUVIMED